2010
DOI: 10.1111/j.1365-2753.2009.01262.x
|View full text |Cite
|
Sign up to set email alerts
|

Identifying and prioritizing uncertainties: patient and clinician engagement in the identification of research questions

Abstract: The key outcome is the generation of a prioritized list of treatment uncertainties in asthma, agreed by a collaboration of patients and health professionals, to inform the commissioning of new research. Such a large number of patient-identified treatment uncertainties had not previously been identified in the literature, an indication perhaps that asthma self-management is a neglected research area. Whether the results have an influence of research funding decisions is not yet known.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
96
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 93 publications
(104 citation statements)
references
References 10 publications
5
96
0
1
Order By: Relevance
“…The partnership between the British Thoracic Society and Asthma UK was the first formal PSP to complete the JLA process [7]. There have since been eight further completed PSPs, with the Ear, Nose and Throat specialty contributing two completed partnerships (balance and tinnitus).…”
Section: The Jlamentioning
confidence: 99%
“…The partnership between the British Thoracic Society and Asthma UK was the first formal PSP to complete the JLA process [7]. There have since been eight further completed PSPs, with the Ear, Nose and Throat specialty contributing two completed partnerships (balance and tinnitus).…”
Section: The Jlamentioning
confidence: 99%
“…For example, ‘ What are the adverse effects associated with long-term use of short- and long-acting bronchodilators; inhaled and oral steroids; and combination and additive therapies in children? ’ 83. Cost-effectiveness was prioritised in three studies 14 43 73.…”
Section: Resultsmentioning
confidence: 99%
“…This sample size was estimated on the basis of previous James Lind Alliance PSPs 438 and determined by the time frame available for the vitiligo PSP. Data from all stages were stored and analysed in Microsoft Access ® 2007 (Microsoft Corporation, Redmond, WA, USA) and processed by the Steering Group members.…”
Section: Methodsmentioning
confidence: 99%